Emmaus Life Sciences EMMA Cash Flow Statement (2010-2026)

OTC EMMA
$0.05 -0.01 (-16.67%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Emmaus Life Sciences Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Emmaus Life Sciences reported cash from operations of $1.69M and free cash flow of $1.69M for the quarter ended Jun 2026, up 158.2% year over year. This cash flow statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-3.15M-6.86M-1.54M-8.89M-0.39M0.20M-3.45M-1.56M0.07M1.21M-4.35M-2.18M1.83M-1.75M-2.33M-1.14M-2.08M-1.95M-3.34M1.34M
Depreciation and DepletionDep. & Depletion
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.02M0.02M0.02M0.01M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.38M0.40M0.41M0.36M0.53M0.51M0.58M0.68M0.58M0.72M0.49M0.07M0.07M0.08M0.10M0.13M0.14M0.19M0.16M0.11M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.02M0.02M0.02M0.01M
Share-based CompensationStock Comp.
0.05M0.01M0.01M0.01M0.05M0.06M1.20M0.02M0.02M0.02M0.17M0.03M0.03M0.03M0.01M0.00M0.01M0.01M0.00M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Equity InvestmentsGains Equity
-0.66M-0.73M-0.57M-0.49M-0.43M-0.42M-0.53M-0.44M-0.38M-0.37M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
-0.13M-0.42M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
1.49M-1.13M-3.42M3.15M-3.48M-3.53M0.65M0.68M-3.01M-1.84M-0.24M1.44M-2.32M-0.83M0.15M0.21M0.29M0.41M0.30M-0.24M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.69M-1.62M-0.10M0.29M0.30M-1.09M1.83M3.38M-0.99M0.93M-2.53M1.61M0.39M-2.36M-0.56M0.01M0.55M0.19M-0.76M-1.34M
Change in InventoryChange Inventory
-0.17M-0.06M-0.14M-0.09M-0.16M-0.04M-0.16M-0.38M-0.09M-0.01M-0.17M0.12M-0.04M0.08M-0.20M-0.12M-0.11M0.45M0.35M-0.32M
Change in Accured ExpensesChange Accured Exp.
0.71M2.23M0.53M0.64M0.31M2.20M1.00M1.20M0.27M2.33M1.47M0.76M-0.34M-0.59M1.35M1.11M2.41M1.58M1.87M-1.01M
Change in TaxesChange Taxes
0.03M-0.05M0.01M0.05M-0.04M0.00M
Change in Other Operating AssetsOther Assets Change
-0.34M-0.04M-0.27M-0.41M0.06M0.04M-0.43M-0.19M0.55M0.04M-0.35M-0.53M-0.10M-0.50M-0.50M-0.18M-0.12M0.61M-0.32M0.00M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.32M0.20M-3.42M-0.01M0.29M0.05M-0.57M-2.18M0.38M-0.57M-0.49M-2.30M0.77M0.53M-0.27M-2.67M-0.57M2.97M-0.08M-1.29M
Other Working Capital ChangesOther WC Changes
0.03M0.24M-3.15M0.40M0.23M0.01M-0.15M-1.99M-0.17M-0.61M-0.14M-1.76M0.87M1.03M0.23M-2.49M-0.45M2.36M0.25M-1.30M
Cash from OperationsCash from Ops.
1.64M0.87M-4.73M-1.06M-0.95M1.68M-1.29M-1.31M0.06M1.04M0.14M-2.92M0.15M0.34M0.28M-2.91M0.41M2.21M-0.34M1.69M
Investing Activities
Capital ExpendituresCapex
0.01M0.06M0.00M0.02M0.01M0.01M0.01M0.01M0.00M0.00M0.00M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.06M0.00M-0.02M-0.01M-0.01M-0.01M-0.01M0.00M0.00M0.00M-0.01M
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
2.92M
Cash from Investing ActivitiesCash from Investing
-1.29M-1.13M1.23M-1.65M-0.90M-1.06M-1.09M1.06M-0.40M-0.01M0.00M2.51M0.00M0.00M2.17M1.58M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.30M0.70M2.06M2.98M4.71M0.62M2.71M0.97M4.25M2.04M1.40M1.00M0.80M0.91M1.21M2.03M1.32M3.35M1.11M
Long-Term Debt RepaymentsLT Debt Repayment
0.50M2.60M0.45M0.57M1.12M3.76M2.05M2.36M0.77M1.24M1.11M1.55M1.75M2.33M3.71M1.81M1.54M
Non-Current Debt
0.30M0.20M2.06M2.98M2.11M0.17M2.14M-0.15M0.49M-0.01M-0.96M0.24M-0.44M-0.20M-0.35M0.28M-1.00M-0.36M-0.70M-1.54M
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
0.30M0.20M2.06M2.98M2.11M0.17M2.14M-0.15M0.49M-0.01M-0.96M0.24M-0.44M-0.20M-0.35M0.28M-1.00M-0.36M-0.70M-1.54M
Change in Capital Stock
Common Stock IssuedStock Issued
Net Shares Issued and RepurchasedNet Shares Issued
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.30M0.20M2.06M2.89M2.11M0.17M2.14M-0.15M0.49M-0.01M-0.96M0.24M-0.44M-0.20M-0.35M0.28M-1.00M-0.36M-0.70M-1.54M
Additional items
Exchange Rate EffectFX Effect
0.00M0.02M-0.02M-0.01M-0.06M0.06M-0.01M-0.02M-0.01M0.02M-0.02M-0.01M0.02M-0.01M0.01M0.01M0.00M-0.01M-0.01M
Change in Cash
0.65M-0.04M-1.47M0.17M0.20M0.84M-0.25M-0.41M0.14M1.04M-0.84M-0.19M-0.27M0.13M-0.06M-0.45M-0.59M1.83M-1.06M1.74M
Ending Cash Balance
2.32M2.28M0.81M0.98M1.18M2.02M1.77M1.36M1.51M2.55M1.71M1.53M1.26M1.39M1.33M0.89M0.29M2.13M1.07M2.81M
Free Cash FlowFCF
1.63M0.80M-4.74M-1.08M-0.95M1.67M-1.30M-1.31M0.06M1.03M0.14M-2.92M0.15M0.34M0.28M-2.91M0.41M2.21M-0.34M1.69M
Net Cash FlowNCF
0.65M-0.06M-1.45M0.18M0.26M0.79M-0.24M-0.39M0.15M1.03M-0.82M-0.18M-0.29M0.15M-0.07M-0.45M-0.59M1.85M-1.05M1.74M
Interest Paid
0.25M0.11M0.21M0.07M0.53M0.52M0.28M0.74M0.66M0.77M0.87M0.36M0.51M0.50M0.42M0.50M0.73M0.88M0.81M0.71M
Income Taxes PaidTaxes Paid
0.00M-0.02M0.00M0.01M-0.01M0.00M-0.07M0.10M0.05M0.02M0.01M0.02M0.00M0.01M0.01M0.00M0.00M

Emmaus Life Sciences Cash Flow Statement API

Pull Emmaus Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EMMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY